{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["colon cancer", "gefitinib", "gene expression", "histopathological examination", "nanoparticles", "nanosized cubosomes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36840004", "DateRevised": {"Year": "2023", "Month": "02", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "17"}], "Language": ["eng"], "ELocationID": ["680", "10.3390/pharmaceutics15020680"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "15", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "17"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer.", "Abstract": {"AbstractText": ["Gefitinib (GFT) is a tyrosine kinase inhibitor drug used as a first-line treatment for patients with advanced or metastatic non-small cell lung, colon, and breast cancer. GFT exhibits low solubility and hence low oral bioavailability, which restricts its clinical application. One of the most important trends in overcoming such problems is the use of a vesicular system. Cubosomes are considered one of the most important vesicular systems used to improve solubility and oral bioavailability. In this study, GFT cubosomal nanoparticles (GFT-CNPs) were prepared by the emulsification method. The selected formulation variables were analyzed and optimized by full factorial design and response surface methodology. Drug entrapment efficiency (EE%), transmission electron microscopy, particle size, polydispersity index, in vitro release and its kinetics, and the effect of storage studies were estimated. The chosen GFT-CNPs were subjected to further investigations as gene expression levels of tissue inhibitors of metalloproteinases-1 (TIMP-1) and matrix metalloproteinases-7 (MMP-7), colon biomarkers, and histopathological examination of colon tissues. The prepared GFT-CNPs were semi-cubic in shape, with high EE%, smaller vesicle size, and higher zeta potential values. The in vivo data showed a significant decrease in the serum level of embryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), and gene expression level of TIMP-1 and MMP-7. Histopathological examination showed enhancement in cancer tissue and highly decreased focal infiltration in the lamina propria after treatment with GFT-CNPs."]}, "AuthorList": [{"Identifier": ["0000-0003-0875-1602"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt."}], "LastName": "El-Shenawy", "ForeName": "Ahmed A", "Initials": "AA"}, {"Identifier": ["0000-0001-9547-2243"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt."}], "LastName": "Elsayed", "ForeName": "Mahmoud M A", "Initials": "MMA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Pharmacy, Port Said University, Port Said 42515, Egypt."}], "LastName": "Atwa", "ForeName": "Gamal M K", "Initials": "GMK"}, {"Identifier": ["0000-0003-1348-6567"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Abourehab", "ForeName": "Mohammed A S", "Initials": "MAS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt."}], "LastName": "Mohamed", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": ["0000-0002-9179-4373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Ghoneim", "ForeName": "Mohammed M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt."}], "LastName": "Mahmoud", "ForeName": "Reda A", "Initials": "RA"}, {"Identifier": ["0000-0001-8327-7192"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt."}], "LastName": "Sabry", "ForeName": "Shereen A", "Initials": "SA"}, {"Identifier": ["0000-0003-0322-5064"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Cairo 11751, Egypt."}], "LastName": "Anwar", "ForeName": "Walid", "Initials": "W"}, {"Identifier": ["0000-0002-0814-1743"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O. Box 71666, Riyadh 11597, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Anatomy, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "El-Sherbiny", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 35712, Egypt."}], "LastName": "Hassan", "ForeName": "Yasser A", "Initials": "YA"}, {"Identifier": ["0000-0003-1045-0163"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}], "LastName": "Belal", "ForeName": "Amany", "Initials": "A"}, {"Identifier": ["0000-0003-0812-0149"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Faculty of Pharmacy, Port Said University, Port Said 42515, Egypt."}], "LastName": "Ramadan", "ForeName": "Abd El Hakim", "Initials": "AEH"}], "GrantList": [{"GrantID": "22UQU4290565DSR117", "Agency": "Umm al-Qura University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbas Z., Rehman S. An overview of cancer treatment modalities. Neoplasm. 2018;1:139\u2013157."}, {"Citation": "Elsayed M.M., Mostafa M.E., Alaaeldin E., Sarhan H.A., Shaykoon M.S., Allam S., Ahmed A.R., Elsadek B.E. Design and characterisation of novel Sorafenib-loaded carbon nanotubes with distinct tumour-suppressive activity in hepatocellular carcinoma. Int. J. Nanomed. 2019;14:8445\u20138467. doi: 10.2147/IJN.S223920.", "ArticleIdList": ["10.2147/IJN.S223920", "PMC6825507", "31754301"]}, {"Citation": "Hassnine A.A., Saber M.A., Fouad Y.M., Sarhan H., Elsayed M.M., Zaki Z.M., Abdelraheem E.M., Abdelhalim S.M., Elsayed A.M. Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt. Virus Res. 2022;323:198953. doi: 10.1016/j.virusres.2022.198953.", "ArticleIdList": ["10.1016/j.virusres.2022.198953", "PMC10194353", "36209916"]}, {"Citation": "Bhandari A., Woodhouse M., Gupta S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: A SEER-based analysis with comparison to other young-onset cancers. J. Investig. Med. 2017;65:311\u2013315. doi: 10.1136/jim-2016-000229.", "ArticleIdList": ["10.1136/jim-2016-000229", "PMC5564445", "27864324"]}, {"Citation": "Saddik M.S., Elsayed M.M., Abdelkader M.S.A., El-Mokhtar M.A., Abdel-Aleem J.A., Abu-Dief A.M., Al-Hakkani M.F., Farghaly H.S., Abou-Taleb H.A. Novel green biosynthesis of 5-fluorouracil chromium nanoparticles using harpullia pendula extract for treatment of colorectal cancer. Pharmaceutics. 2021;13:226\u2013243. doi: 10.3390/pharmaceutics13020226.", "ArticleIdList": ["10.3390/pharmaceutics13020226", "PMC7915530", "33562032"]}, {"Citation": "Rawla P., Sunkara T., Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Przegl\u0105d Gastroenterol. 2019;14:89\u2013103. doi: 10.5114/pg.2018.81072.", "ArticleIdList": ["10.5114/pg.2018.81072", "PMC6791134", "31616522"]}, {"Citation": "Saber M.A., Sarhan H.A.-M., Fouad Y.M., Elsayed M., Hassnine A.A. Overview on Hepatitis B vaccination. Egypt. J. Hosp. Med. 2022;86:696\u2013699. doi: 10.21608/ejhm.2022.215573.", "ArticleIdList": ["10.21608/ejhm.2022.215573", "PMC10194353", "36209916"]}, {"Citation": "Raskov H., S\u00f8by J.H., Troelsen J., Bojesen R.D., G\u00f6genur I. Driver gene mutations and epigenetics in colorectal cancer. Ann. Surg. 2020;271:75\u201385. doi: 10.1097/SLA.0000000000003393.", "ArticleIdList": ["10.1097/SLA.0000000000003393", "31188207"]}, {"Citation": "Mirnezami A., Mirnezami R., Chandrakumaran K., Sasapu K., Sagar P., Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: Systematic review and meta-analysis. Ann. Surg. 2011;253:890\u2013899. doi: 10.1097/SLA.0b013e3182128929.", "ArticleIdList": ["10.1097/SLA.0b013e3182128929", "21394013"]}, {"Citation": "Nawale V., Darekar A., Saudagar R. Micro-RNA: Biomarker for the treatment of cancer. J. Drug Deliv. Ther. 2019;9:511\u2013524."}, {"Citation": "van den Heuvel M.M., Verheij M., Boshuizen R., Belderbos J., Dingemans A.-M.C., De Ruysscher D., Laurent J., Tighe R., Haanen J., Quaratino S. NHS-IL2 combined with radiotherapy: Preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy. J. Transl. Med. 2015;13:32. doi: 10.1186/s12967-015-0397-0.", "ArticleIdList": ["10.1186/s12967-015-0397-0", "PMC4320467", "25622640"]}, {"Citation": "Ahmed M.M. Effect of different formulation variables on release characteristics of gastro-floating microspheres of ethyl cellulose/carbopol 934P encapsulating sorafenib. Int. J. Pharm. Pharm. Sci. 2019;11:64\u201370. doi: 10.22159/ijpps.2019v11i10.34290.", "ArticleIdList": ["10.22159/ijpps.2019v11i10.34290"]}, {"Citation": "Chavda H., Patel C., Anand I. Biopharmaceutics classification system. Syst. Rev. Pharm. 2010;1:62\u201371. doi: 10.4103/0975-8453.59514.", "ArticleIdList": ["10.4103/0975-8453.59514"]}, {"Citation": "Elsayed M. Controlled release alginate-chitosan microspheres of tolmetin sodium prepared by internal gelation technique and characterized by response surface modeling. Braz. J. Pharm. Sci. 2021;56:1\u201316. doi: 10.1590/s2175-97902020000118414.", "ArticleIdList": ["10.1590/s2175-97902020000118414"]}, {"Citation": "Ma S., Xu Y., Deng Q., Yu X. Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population. Lung Cancer. 2009;65:198\u2013203. doi: 10.1016/j.lungcan.2008.10.028.", "ArticleIdList": ["10.1016/j.lungcan.2008.10.028", "19091441"]}, {"Citation": "Alshehri S., Alanazi A., Elzayat E.M., Altamimi M.A., Imam S.S., Hussain A., Alqahtani F., Shakeel F. Formulation, in vitro and in vivo evaluation of gefitinib solid dispersions prepared using different techniques. Processes. 2021;9:1210. doi: 10.3390/pr9071210.", "ArticleIdList": ["10.3390/pr9071210"]}, {"Citation": "Hasan A., Abd Elghany M., Sabry S. Design and characterization of intra-oral fast dissolving tablets containing diacerein-solid dispersion. J. Appl. Pharm. Sci. 2020;10:44\u201353."}, {"Citation": "El-Rasoul A., Ahmed M.M. Chitosan polymer as a coat of calcium alginate microcapsules loaded by non-steroidal antiinflammatory drug. Bull. Pharm. Sci. Assiut. 2010;33:179\u2013186. doi: 10.21608/bfsa.2010.64750.", "ArticleIdList": ["10.21608/bfsa.2010.64750"]}, {"Citation": "Elsayed M., Elgarhy O., Abdelkader H., Elkhayat O. Enhancement of Etodolac Solubility Using Solid Dispersion Technique: Full Factorial Design Optimization and In Vitro Release Studies. SJYR. 2022;2:46\u201354. doi: 10.21608/sjyr.2022.228858.", "ArticleIdList": ["10.21608/sjyr.2022.228858"]}, {"Citation": "Ahmed M.M., Abd El-Rasoul S., Auda S.H., Ibrahim M.A. Emulsification/internal gelation as a method for preparation of diclofenac sodium\u2013sodium alginate microparticles. Saudi Pharm. J. 2013;21:61\u201369. doi: 10.1016/j.jsps.2011.08.004.", "ArticleIdList": ["10.1016/j.jsps.2011.08.004", "PMC3745083", "23960820"]}, {"Citation": "Abd El Rasoul S., Saleh K. Emulsion solvent evaporation method for preparing Eudragit RS100 microparticles loaded ketorolac tromethamine. Asian J. Pharm. Health Sci. 2013;3:627\u2013639."}, {"Citation": "Elsayed M., El Rasoul S.A., Hussein A.K. Response surface methodology as a useful tool for development and optimization of sustained release ketorolac tromethamine niosomal organogels. J. Pharm. Innov. 2020;15:664\u2013677. doi: 10.1007/s12247-019-09421-4.", "ArticleIdList": ["10.1007/s12247-019-09421-4"]}, {"Citation": "Sabry S., Okda T., Hasan A. Formulation, characterization, and evaluation of the anti-tumor activity of nanosized galangin loaded niosomes on chemically induced hepatocellular carcinoma in rats. J. Drug Deliv. Sci. Technol. 2021;61:102\u2013116. doi: 10.1016/j.jddst.2020.102163.", "ArticleIdList": ["10.1016/j.jddst.2020.102163"]}, {"Citation": "Elsayed M.M.A., Okda T.M., Atwa G.M.K., Omran G.A., Abd Elbaky A.E., Ramadan A.E.h. Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma. Pharmaceutics. 2021;13:648. doi: 10.3390/pharmaceutics13050648.", "ArticleIdList": ["10.3390/pharmaceutics13050648", "PMC8147467", "34063274"]}, {"Citation": "Auda S.H., El-Rasoul S.A., Ahmed M.M., Osman S.K., El-Badry M. In-vitro release and in-vivo performance of tolmetin from different topical gel formulations. J. Pharm. Investig. 2015;45:311\u2013317. doi: 10.1007/s40005-015-0174-3.", "ArticleIdList": ["10.1007/s40005-015-0174-3"]}, {"Citation": "Saddik M.S., Elsayed M.M., El-Mokhtar M.A., Sedky H., Abdel-Aleem J.A., Abu-Dief A.M., Al-Hakkani M.F., Hussein H.L., Al-Shelkamy S.A., Meligy F.Y. Tailoring of novel azithromycin-loaded zinc oxide nanoparticles for wound healing. Pharmaceutics. 2022;14:111. doi: 10.3390/pharmaceutics14010111.", "ArticleIdList": ["10.3390/pharmaceutics14010111", "PMC8780377", "35057019"]}, {"Citation": "Dhadwal A., Sharma D.R., Pandit V., Ashawat M.S., Kumar P. Cubosomes: A novel carrier for transdermal drug delivery. J. Drug Deliv. Ther. 2020;10:123\u2013130. doi: 10.22270/jddt.v10i1.3814.", "ArticleIdList": ["10.22270/jddt.v10i1.3814"]}, {"Citation": "Mourelatou E.A., Sarigiannis Y., Petrou C.C. Ocular Drug Delivery Nanosystems: Recent Developments and Future Challenges. Drug Deliv. Nanosyst. 2019;2019:93\u2013172."}, {"Citation": "Jain S., Jain V., Mahajan S. Lipid based vesicular drug delivery systems. Adv. Pharm. 2014;2014:1\u201316. doi: 10.1155/2014/574673.", "ArticleIdList": ["10.1155/2014/574673"]}, {"Citation": "Mathias N.R., Hussain M.A. Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration. J. Pharm. Sci. 2010;99:1\u201320. doi: 10.1002/jps.21793.", "ArticleIdList": ["10.1002/jps.21793", "19499570"]}, {"Citation": "Duttagupta A.S., Chaudhary H.M., Jadhav K.R., Kadam V.J. Cubosomes: Innovative nanostructures for drug delivery. Curr. Drug Deliv. 2016;13:482\u2013493. doi: 10.2174/1567201812666150224114751.", "ArticleIdList": ["10.2174/1567201812666150224114751", "25707403"]}, {"Citation": "Mohsen A.M., Younis M.M., Salama A., Darwish A.B. Cubosomes as a potential oral drug delivery system for enhancing the hepatoprotective effect of coenzyme Q10. J. Pharm. Sci. 2021;110:2677\u20132686. doi: 10.1016/j.xphs.2021.02.007.", "ArticleIdList": ["10.1016/j.xphs.2021.02.007", "33600809"]}, {"Citation": "Gaballa S.A., El Garhy O.H., Abdelkader H. Cubosomes: Composition, preparation, and drug delivery applications. J. Adv. Biomed. Pharm. Sci. 2020;3:1\u20139. doi: 10.21608/jabps.2019.16887.1057.", "ArticleIdList": ["10.21608/jabps.2019.16887.1057"]}, {"Citation": "Refaat H., Naguib Y.W., Elsayed M.M., Sarhan H.A., Alaaeldin E. Modified spraying technique and response surface methodology for the preparation and optimization of propolis liposomes of enhanced anti-proliferative activity against human melanoma cell line A375. Pharmaceutics. 2019;11:558. doi: 10.3390/pharmaceutics11110558.", "ArticleIdList": ["10.3390/pharmaceutics11110558", "PMC6921042", "31661945"]}, {"Citation": "Morsi N.M., Abdelbary G.A., Ahmed M.A. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: Development and in vitro/in vivo characterization. Eur. J. Pharm. Biopharm. 2014;86:178\u2013189. doi: 10.1016/j.ejpb.2013.04.018.", "ArticleIdList": ["10.1016/j.ejpb.2013.04.018", "23688805"]}, {"Citation": "Singhal K., Kaushik N., Kumar A. Cubosomes: Versatile Nanosized Formulation for Efficient Delivery of Therapeutics. Curr. Drug Deliv. 2022;19:644\u2013657.", "ArticleIdList": ["34238187"]}, {"Citation": "Saddik M.S., Elsayed M.M., Abdel-Rheem A.A., El-Mokhtar M.A., Mosa E.S., Al-Hakkani M.F., Al-Shelkamy S.A., Khames A., Daha M.A., Abdel-Aleem J.A. A Novel C@ Fe@ Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma. Pharmaceutics. 2022;14:1845. doi: 10.3390/pharmaceutics14091845.", "ArticleIdList": ["10.3390/pharmaceutics14091845", "PMC9505246", "36145592"]}, {"Citation": "Elsayed M., Aboelez M.O., Elsadek B.E., Sarhan H.A., Khaled K.A., Belal A., Khames A., Hassan Y.A., Abdel-Rheem A.A., Elkaeed E.B.J.P. Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology. Pharmaceutics. 2022;14:880. doi: 10.3390/pharmaceutics14040880.", "ArticleIdList": ["10.3390/pharmaceutics14040880", "PMC9027483", "35456714"]}, {"Citation": "Auda S.H., Ahmed M.M., El-Rasoul A., Saleh K.I. Formulation and physicochemical characterization of piroxicam containing polymer films. Bull. Pharm. Sci. Assiut. 2010;33:33\u201342. doi: 10.21608/bfsa.2010.147018.", "ArticleIdList": ["10.21608/bfsa.2010.147018"]}, {"Citation": "Hesham M., Jelan A., Mahmoud A. Development and optimization of itopride hydrochloride fast disintegrating tablets using factorial design and response surface methodology. Int. J. Pharm. Sci. Res. 2015;6:1661\u20131672."}, {"Citation": "El-Shenawy A.A., Ahmed M.M., Mansour H.F., Abd El Rasoul S. Torsemide fast dissolving tablets: Development, optimization using Box\u2013Bhenken design and response surface methodology, in vitro characterization, and pharmacokinetic assessment. AAPS PharmSciTech. 2017;18:2168\u20132179. doi: 10.1208/s12249-016-0697-6.", "ArticleIdList": ["10.1208/s12249-016-0697-6", "28050711"]}, {"Citation": "Ahmed M.M., Auda S.H., El-Rasoul A., Saleh K.I., Zayed G.M. Preparation and Evaluation of Diclofenac Sodium\u2013Cellulose Acetate Microcapsules Using Solvent Evaporation Technique. Bull. Pharm. Sci. Assiut. 2010;33:43\u201349. doi: 10.21608/bfsa.2010.147021.", "ArticleIdList": ["10.21608/bfsa.2010.147021"]}, {"Citation": "Fornasier M., Biffi S., Bortot B., Macor P., Manhart A., Wurm F.R., Murgia S. Cubosomes stabilized by a polyphosphoester-analog of Pluronic F127 with reduced cytotoxicity. J. Colloid Interface Sci. 2020;580:286\u2013297. doi: 10.1016/j.jcis.2020.07.038.", "ArticleIdList": ["10.1016/j.jcis.2020.07.038", "32688121"]}, {"Citation": "Elsayed M. Design and optimization of tolmetin sodium microspheres prepared by emulsification-internal gelation using response surface methodology. Al-Azhar J. Pharm. Sci. 2012;45:383\u2013398. doi: 10.21608/ajps.2012.7249.", "ArticleIdList": ["10.21608/ajps.2012.7249"]}, {"Citation": "El-Rasoul A., Ahmed M.M. Preparation, characterization and in-vitro release of controlled release ketorolac tromethamine cellulose acetate butyrate microspheres. Bull. Pharm. Sci. Assiut. 2010;33:187\u2013199. doi: 10.21608/bfsa.2010.64752.", "ArticleIdList": ["10.21608/bfsa.2010.64752"]}, {"Citation": "Zewail M., Gaafar P.M.E., Ali M.M., Abbas H. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management. Drug Deliv. 2022;29:1663\u20131674. doi: 10.1080/10717544.2022.2079770.", "ArticleIdList": ["10.1080/10717544.2022.2079770", "PMC9154769", "35616281"]}, {"Citation": "Teaima M., Abdelmonem R., Adel Y.A., El-Nabarawi M.A., El-Nawawy T.M. Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats. Drug Des. Dev. Ther. 2021;15:4603\u20134621. doi: 10.2147/DDDT.S327860.", "ArticleIdList": ["10.2147/DDDT.S327860", "PMC8590984", "34785889"]}, {"Citation": "Elsayed M.M., Aboelez M.O., Mohamed M.S., Mahmoud R.A., El-Shenawy A.A., Mahmoud E.A., Al-Karmalawy A.A., Santali E.Y., Alshehri S., Elsadek M.E.M. Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study. Pharmaceutics. 2022;14:1629. doi: 10.3390/pharmaceutics14081629.", "ArticleIdList": ["10.3390/pharmaceutics14081629", "PMC9412892", "36015255"]}, {"Citation": "El-Shenawy A.A., Mahmoud R.A., Mahmoud E.A., Mohamed M.S. Intranasal in situ gel of apixaban-loaded nanoethosomes: Preparation, optimization, and in vivo evaluation. AAPS PharmSciTech. 2021;22:147. doi: 10.1208/s12249-021-02020-y.", "ArticleIdList": ["10.1208/s12249-021-02020-y", "33948767"]}, {"Citation": "Shah K.U., Khan G.M. Regulating drug release behavior and kinetics from matrix tablets based on fine particle-sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation. Sci. World J. 2012;2012:1\u20138. doi: 10.1100/2012/842348.", "ArticleIdList": ["10.1100/2012/842348", "PMC3350987", "22649325"]}, {"Citation": "Dash S., Murthy P.N., Nath L., Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 2010;67:217\u2013223.", "ArticleIdList": ["20524422"]}, {"Citation": "Kalam M.A., Humayun M., Parvez N., Yadav S., Garg A., Amin S., Sultana Y., Ali A. Release kinetics of modified pharmaceutical dosage forms: A review. Cont. J. Pharm. Sci. 2007;1:30\u201335."}, {"Citation": "Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983;15:25\u201335. doi: 10.1016/0378-5173(83)90064-9.", "ArticleIdList": ["10.1016/0378-5173(83)90064-9", "6644570"]}, {"Citation": "Elkot M., Elsayed M., Alaaeldin E., Sarhan H., Shaykoon M.S.A., Elsadek B. Accelerated stability testing of microcapsulated sorafenib-loaded carbon nanotubes prepared by emulsification/internal gelation method. Int. J. Pharm. Pharm. Res. 2019;16:126\u2013139."}, {"Citation": "Abass S.A., Abdel-Hamid N.M., Abouzed T.K., El-Shishtawy M.M. Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma. Biomed. Pharmacother. 2018;101:710\u2013718. doi: 10.1016/j.biopha.2018.02.128.", "ArticleIdList": ["10.1016/j.biopha.2018.02.128", "29524879"]}, {"Citation": "Nirmala P., Ramanathan M. Effect of myricetin on 1,2 dimethylhydrazine induced rat colon carcinogenesis. J. Exp. Ther. Oncol. 2011;9:101\u2013118.", "ArticleIdList": ["21699017"]}, {"Citation": "Lubet R.A., Szabo E., Christov K., Bode A.M., Ericson M.E., Steele V.E., Juliana M.M., Grubbs C.J. Effects of gefitinib (Iressa) on mammary cancers: Preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes. Mol. Cancer Ther. 2008;7:972\u2013982. doi: 10.1158/1535-7163.MCT-07-2141.", "ArticleIdList": ["10.1158/1535-7163.MCT-07-2141", "18375820"]}, {"Citation": "Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212\u0394\u0394C(T)) Method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Bancroft J.D. Observations on the effect on histochemical reactions of different processing methods. J. Med. Lab. Technol. 1966;23:105\u2013108.", "ArticleIdList": ["5931043"]}, {"Citation": "Eldeeb A.E., Salah S., Ghorab M. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: Ex-vivo permeation and in-vivo pharmacodynamic study. J. Drug Deliv. Sci. Technol. 2019;52:236\u2013247. doi: 10.1016/j.jddst.2019.04.036.", "ArticleIdList": ["10.1016/j.jddst.2019.04.036"]}, {"Citation": "Hashem F., Nasr M., Youssif M. Formulation and characterization of cubosomes containing REB for improvement of oral absorption of the drug in human volunteers. J. Adv. Pharm. Res. 2018;2:95\u2013103. doi: 10.21608/aprh.2018.5828.", "ArticleIdList": ["10.21608/aprh.2018.5828"]}, {"Citation": "Matloub A.A., AbouSamra M.M., Salama A.H., Rizk M.Z., Aly H.F., Fouad G.I. Cubic liquid crystalline nanoparticles containing a polysaccharide from Ulva fasciata with potent antihyperlipidaemic activity. Saudi Pharm. J. 2018;26:224\u2013231. doi: 10.1016/j.jsps.2017.12.007.", "ArticleIdList": ["10.1016/j.jsps.2017.12.007", "PMC6111190", "30166920"]}, {"Citation": "Nasr M., Younes H., Abdel-Rashid R.S. Formulation and evaluation of cubosomes containing colchicine for transdermal delivery. Drug Deliv. Transl. Res. 2020;10:1302\u20131313. doi: 10.1007/s13346-020-00785-6.", "ArticleIdList": ["10.1007/s13346-020-00785-6", "32399604"]}, {"Citation": "Eissa E.M., Elkomy M.H., Eid H.M., Ali A.A., Abourehab M.A., Alsubaiyel A.M., Naguib I.A., Alsalahat I., Hassan A.H. Intranasal delivery of granisetron to the brain via nanostructured cubosomes-based in situ gel for improved management of chemotherapy-induced emesis. Pharmaceutics. 2022;14:1374. doi: 10.3390/pharmaceutics14071374.", "ArticleIdList": ["10.3390/pharmaceutics14071374", "PMC9316995", "35890270"]}, {"Citation": "Kumar A., Hodnett B.K., Hudson S., Davern P. Modification of the zeta potential of montmorillonite to achieve high active pharmaceutical ingredient nanoparticle loading and stabilization with optimum dissolution properties. Colloids Surf. B Biointerfaces. 2020;193:111\u2013120. doi: 10.1016/j.colsurfb.2020.111120.", "ArticleIdList": ["10.1016/j.colsurfb.2020.111120", "32505995"]}, {"Citation": "Gaballa S.A., El Garhy O.H., Moharram H., Abdelkader H. Preparation and evaluation of cubosomes/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis. Pharm. Res. 2020;37:198. doi: 10.1007/s11095-020-02857-1.", "ArticleIdList": ["10.1007/s11095-020-02857-1", "32968868"]}, {"Citation": "Chettupalli A.K., Ananthula M., Amarachinta P.R., Bakshi V., Yata V.K. Design, Formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel. Biointerface Res. Appl. Chem. 2021;11:12037\u201312054."}, {"Citation": "Nazaruk E., Majkowska-Pilip A., Bilewicz R. Lipidic cubic-phase nanoparticles\u2014Cubosomes for efficient drug delivery to cancer cells. Chempluschem. 2017;82:570\u2013575. doi: 10.1002/cplu.201600534.", "ArticleIdList": ["10.1002/cplu.201600534", "31961592"]}, {"Citation": "Wu L., Zhou W., Lin L., Chen A., Feng J., Qu X., Zhang H., Yue J. Delivery of therapeutic oligonucleotides in nanoscale. Bioact. Mater. 2022;7:292\u2013323. doi: 10.1016/j.bioactmat.2021.05.038.", "ArticleIdList": ["10.1016/j.bioactmat.2021.05.038", "PMC8379367", "34466734"]}, {"Citation": "Nithya R., Jerold P., Siram K. Cubosomes of dapsone enhanced permeation across the skin. J. Drug Deliv. Sci. Technol. 2018;48:75\u201381. doi: 10.1016/j.jddst.2018.09.002.", "ArticleIdList": ["10.1016/j.jddst.2018.09.002"]}, {"Citation": "Meng C., Yin X., Liu J., Tang K., Tang H., Liao J. TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis. PLoS ONE. 2018;13:e0207039. doi: 10.1371/journal.pone.0207039.", "ArticleIdList": ["10.1371/journal.pone.0207039", "PMC6245680", "30458003"]}, {"Citation": "Koskensalo S., Louhimo J., Nordling S., Hagstr\u00f6m J., Haglund C. MMP-7 as a prognostic marker in colorectal cancer. Tumor Biol. 2011;32:259\u2013264. doi: 10.1007/s13277-010-0080-2.", "ArticleIdList": ["10.1007/s13277-010-0080-2", "21207220"]}, {"Citation": "Vukobrat-Bijedic Z., Husic-Selimovic A., Sofic A., Bijedic N., Bjelogrlic I., Gogov B., Mehmedovic A. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. Med. Arch. 2013;67:397\u2013401. doi: 10.5455/medarh.2013.67.397-401.", "ArticleIdList": ["10.5455/medarh.2013.67.397-401", "PMC4272469", "25568506"]}, {"Citation": "Lakemeyer L., Sander S., Wittau M., Henne-Bruns D., Kornmann M., Lemke J. Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer. Diseases. 2021;9:21. doi: 10.3390/diseases9010021.", "ArticleIdList": ["10.3390/diseases9010021", "PMC8006010", "33802962"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "5"}, {"Year": "2023", "Month": "2", "Day": "14"}, {"Year": "2023", "Month": "2", "Day": "14"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "4", "Minute": "21"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["36840004", "PMC9960579", "10.3390/pharmaceutics15020680", "pharmaceutics15020680"]}}], "PubmedBookArticle": []}